Découvrez la nouvelle édition du baromètre réalisé par Direct Medica sur la vision des pharmaciens sur les objets connectés. Cette année le baromètre compare la vision des pharmaciens et des médecins.
Ce baromètre a été présenté à Pharmagora avec le Moniteur des pharmacies, Egora en partenariat avec Medappcare…
Apple has hired a small team of biomedical engineers to work at a nondescript office in Palo Alto, miles from corporate headquarters. They are part of a super secret initiative, initially envisioned by the late Apple co-founder Steve Jobs, to develop sensors that can non-invasively and continuously monitor blood sugar levels to better treat diabetes, according to three people familiar with the matter.
Such a breakthrough would be a "holy grail" for life sciences. Many life sciences companies have tried and failed, as it's highly challenging to track glucose levels accurately without piercing the skin.
The initiative is far enough along that Apple has been conducting feasibility trials at clinical sites across the Bay Area and has hired consultants to help it figure out the regulatory pathways, the people said.
… speculation has been flying around since the company snapped up about a dozen biomedical experts from companies like Vital Connect, Masimo Corp, Sano, Medtronic, and C8 Medisensors. Some of these people joined the secretive team dedicated to glucose, sources said, while others are on Apple Watch team.
One of the people said that Apple is developing optical sensors, which involves shining a light through the skin to measure indications of glucose. Accurately detecting glucose levels has been such a challenge that one of the top experts in the space, John L. Smith, described it as "the most difficult technical challenge I have encountered in my career." The space is littered with failures, as Smith points out, but that hasn't stopped companies from continuing to attempt to crack this elusive opportunity.
To succeed would cost a company "several hundred millions or even a billion dollars," DexCom executive chairman Terrance Gregg previously told Reuters.
The breakthrough would be a boon for millions of people with diabetes, spur new medical research and open up a potential market for consumers to track their blood sugar for health and wellness insights. It could turn the Apple Watch into a "must have" rather than a "nice to have" for people who would benefit from an easier way to track their blood sugar.
Apple isn't the only technology company eyeing opportunities in the space. Verily, Google's life sciences team, is currently working on a "smart" contact lens to measure blood sugar via the eye (but read “Google’s ‘Smart Lens’ for Glucose Monitoring Not Such a Smart Idea After All!”) and it partnered up with DexCom in 2015 to develop a glucose-sensing device no bigger than a bandage.
Kardia was the very first health sensor I have ever used, and I was fortunate enough to follow its evolution. Now, the company, AliveCor sent me their latest version of the Kardia Mobile heart health monitor. Check out my review below! The progress of a health sensor Alivecor has a special meaning to me, since …
Deux mondes, celui des objets connectés de quantified self et celui des recherches en santé avec l’exploitation des données numériques se sont mis parallèlement en marche depuis une dizaine d’années. Avec pour finalité d’appliquer les progrès des technologies numériques au bien-être et à la médecine de demain.
Wearables are widely used and many healthcare providers are in tune with the wearable health technology market. From smart watches to fitness bands to Google Glass, wearables are widely adopted by consumers.We have collected data and statistics on the trends of wearables and health technology market from various sources and prepared a infographics which depicts healthcare industry scenarios in collaboration of technology.